People · Operator
Named in public records as an officer, director or promoter · active 2009–2012 · Biotechnology
| Company | Role | Sector | Stage | Raised · real | Value · est | Tied |
|---|---|---|---|---|---|---|
| Genelink Inc | — | Biotechnology | Seed | $2.7M | $69.9M | 2009 |
James A Monton at the center, the companies they're named on, and every other operator named alongside them — an interlock map of shared founding teams, boards and funds. Name-matched, so treat as a research lead.
People named alongside James A Monton on the same companies — an interlock signal (shared founding team, board, or fund). Name-matched, so verify before acting.
| Operator | Shared | Their companies |
|---|---|---|
| Bernard L. Kasten | 1 | 3 |
| Douglas M. Boyle | 1 | 1 |
| John H. Souza | 1 | 1 |
| Robert P. Ricciardi | 1 | 1 |
| Robert E. Hoekstra | 1 | 1 |
| Monte E. Taylor | 1 | 1 |
| Susan A Hunt | 1 | 1 |
| Sharon A Tahaney | 1 | 1 |
| Robert Hoekstra | 1 | 1 |
| Gary J. Beeman | 1 | 1 |
| Robert J. Hoekstra | 1 | 1 |
People are matched by normalized name across records; a common name may merge distinct individuals. Treat as a research lead, the same way modeled valuations are directional, not quoted.